The sudden resignation of Peter Marks, M.D., Ph.D., from the FDA branch that regulates biological products for humans ...
Marks offered his resignation while citing Kennedy’s “misinformation and lies” and an “unprecedented assault on scientific ...
The U.S. Food and Drug Administration said on Tuesday it had named Scott Steele as acting director of its Center for ...
As the FDA wavers from cuts, changes and departures under the second Trump administration, another vital figure of the agency ...
More top vaccine regulators at the FDA have either left or been forced out, which could hobble the agency's ability to ...
As the FDA’s top biologics official, Peter Marks oversaw regulation of cell and gene therapies. The departure of Marks and mass layoffs throughout the FDA raise concerns about the agency’s ability to ...
Dr Peter Marks is resigning as director of the FDA's Center for Biologics Evaluation and Research by April 5 due to objections to RFK Jr.
The latest cuts, which are part of a larger reduction of 10,000 at the Department of Health and Human Services, were ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results